Published in J Infect Dis on July 01, 1993
Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol (1997) 2.76
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97
CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A (2004) 1.84
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61
Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med (2001) 1.51
Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol (1996) 1.51
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Physical association of moesin and CD46 as a receptor complex for measles virus. J Virol (1995) 1.48
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol (2006) 1.35
Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33
Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers. Mol Ther (2010) 1.29
Efficiency of measles virus entry and dissemination through different receptors. J Virol (2002) 1.22
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog (2008) 1.15
Attenuated measles virus as a vaccine vector. Vaccine (2007) 1.13
Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci U S A (2006) 1.12
Virus-lymphoid cell interactions. Proc Natl Acad Sci U S A (1996) 1.08
Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J Clin Invest (2003) 1.07
Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol (2002) 1.04
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
Measles virus infection induces terminal differentiation of human thymic epithelial cells. J Virol (1999) 1.00
Converting tumor-specific markers into reporters of oncolytic virus infection. Mol Ther (2009) 0.96
Cell-cell fusion induced by measles virus amplifies the type I interferon response. J Virol (2007) 0.92
Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice. Respir Res (2010) 0.89
Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J Virol (2000) 0.89
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth. J Hepatol (2013) 0.89
Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol (2004) 0.88
Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals. Clin Vaccine Immunol (2006) 0.87
Peste des petits ruminants virus infection of small ruminants: a comprehensive review. Viruses (2014) 0.85
Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther (2010) 0.85
Early events following experimental infection with Peste-Des-Petits ruminants virus suggest immune cell targeting. PLoS One (2013) 0.85
Inhibition of in vitro leukocyte proliferation by morbilliviruses. J Virol (2002) 0.84
CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clin Vaccine Immunol (2012) 0.83
Strain-specific differences in LFA-1 induction on measles virus-infected monocytes and adhesion and viral transmission to endothelial cells. J Virol (1998) 0.81
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clin Exp Immunol (1998) 0.79
Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies. Emerg Infect Dis (2017) 0.79
Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes. J Virol (2003) 0.78
Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line. J Virol (1995) 0.76
Relative ability of different bovine leukocyte populations to support active replication of rinderpest virus. J Virol (1996) 0.76
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (1993) 4.81
Molecular basis of Sindbis virus neurovirulence in mice. J Virol (1988) 3.90
Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J (2001) 3.18
Antigenic shift of visna virus in persistently infected sheep. Science (1977) 3.17
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82
Binding of Sindbis virus to cell surface heparan sulfate. J Virol (1998) 2.82
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol (1996) 2.65
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52
Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A (1998) 2.42
Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun (1999) 2.42
Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol (1977) 2.32
Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31
Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod (2001) 2.26
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Infect Immun (1982) 2.21
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest (1988) 2.05
Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97
Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science (2001) 1.95
Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95
Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis (1976) 1.86
Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J Infect Dis (1991) 1.85
Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci U S A (1994) 1.84
Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80
Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80
Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78
Identification of a putative alphavirus receptor on mouse neural cells. J Virol (1991) 1.78
Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet (1993) 1.75
Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS (2001) 1.75
Differential CD4 T cell activation in measles. J Infect Dis (1993) 1.72
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis (2001) 1.72
In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol (1995) 1.70
Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol (2000) 1.69
Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis (1988) 1.59
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59
Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol (1993) 1.58
Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53
Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol (1992) 1.51
Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice. Infect Immun (1974) 1.51
Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein. Virology (1989) 1.46
Septic arthritis caused by Propionibacterium acnes. JAMA (1982) 1.45
Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J Immunol (1992) 1.45
Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis (1994) 1.44
Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. Infect Immun (1983) 1.43
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42
First the bad news.... CMAJ (1997) 1.40
Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med (1972) 1.39
Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol (1975) 1.39
The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38
Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol (1993) 1.38
Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus. J Virol (1990) 1.38
Early immune responses in visna, a slow viral disease of sheep. J Infect Dis (1978) 1.37
Irlen lenses. J Learn Disabil (1991) 1.37
Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J Immunol (1996) 1.36
Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med (1999) 1.35
Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34
Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol (1988) 1.34
The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol (2000) 1.34
Immune activation in measles. N Engl J Med (1989) 1.33
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis (2005) 1.32
Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J Immunol (1994) 1.32
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol (1996) 1.30
Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization. J Neuropathol Exp Neurol (1991) 1.30
Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J Virol (2000) 1.30
The synthesis and structure of visna virus DNA. Virology (1979) 1.30
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol (2000) 1.29
Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J (1997) 1.29
Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol (1995) 1.29
Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J Virol (1996) 1.28
Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol (1993) 1.28
Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol (1996) 1.25
The role of complement in viral infections. II. the clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement. J Infect Dis (1980) 1.23
Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. J Immunol (1981) 1.23
Monoclonal antibodies to the E1 and E2 glycoproteins of Sindbis virus: definition of epitopes and efficiency of protection from fatal encephalitis. J Gen Virol (1988) 1.23